SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-18-313968
Filing Date
2018-10-31
Accepted
2018-10-31 16:24:58
Documents
4
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A d645222d10qa.htm 10-Q/A 42020
2 EX-2.1 d645222dex21.htm EX-2.1 528175
3 EX-31.1 d645222dex311.htm EX-31.1 3076
4 EX-31.2 d645222dex312.htm EX-31.2 3407
  Complete submission text file 0001193125-18-313968.txt   577988
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-14895 | Film No.: 181150645
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences